Skip to main content

Edgemond James's Form 4 filing

United Therapeutics Corp (UTHR) · filed Sep 17, 2024

Accession no.
0001415889-24-023520
Filed
Sep 17, 2024
Trade date
Sep 16, 2024
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $2.65M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Edgemond JamesCIK 0001636178Officer (CFO AND TREASURER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 16, 2024Common StockMOption exerciseAcquired+3,267$120.26+$392,889.427,007Direct
Sep 16, 2024Common StockSSaleDisposed−3,267$339.12−$1,107,905.043,740Direct
Sep 16, 2024Common StockMOption exerciseAcquired+3,400$117.76+$400,3847,140Direct
Sep 16, 2024Common StockSSaleDisposed−3,400$339.12−$1,153,0083,740Direct
Sep 16, 2024Common StockMOption exerciseAcquired+817$120.26+$98,252.424,557Direct
Sep 16, 2024Common StockSSaleDisposed−562$339.12−$190,585.443,995Direct
Sep 16, 2024Common StockMOption exerciseAcquired+850$117.76+$100,0964,845Direct
Sep 16, 2024Common StockSSaleDisposed−581$339.12−$197,028.724,264Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 16, 2024Common StockMOption exerciseDisposed−3,267$0.00$029,405Direct
Sep 16, 2024Common StockMOption exerciseDisposed−3,400$0.00$0142,100Direct
Sep 16, 2024Common StockMOption exerciseDisposed−817$0.00$028,588Direct
Sep 16, 2024Common StockMOption exerciseDisposed−850$0.00$0141,250Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)